These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30210422)

  • 1. Romiplostim for the Emergency Management of Severe Immune Thrombocytopenia with Intracerebral Hemorrhage.
    Gellens R; Habchi S; Freppel S; Couret D; Iacobelli S
    Front Neurol; 2017; 8():737. PubMed ID: 30210422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.
    Watanabe R; Tabayashi T; Tomikawa T; Sagawa M; Anan-Nemoto T; Kimura Y; Takahashi Y; Tokuhira M; Otaki S; Oi H; Sawano M; Sugiyama S; Kizaki M
    Int J Hematol; 2017 Jan; 105(1):100-103. PubMed ID: 27709451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.
    Al-Jafar H; Giagounidis A; El-Rashaid K; Al-Ali M; Hakim AA
    Ann Pharmacother; 2012 Nov; 46(11):e31. PubMed ID: 23115229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of 5 dogs with immune-mediated thrombocytopenia using Romiplostim.
    Kohn B; Bal G; Chirek A; Rehbein S; Salama A
    BMC Vet Res; 2016 Jun; 12():96. PubMed ID: 27283401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial romiplostim dosing and time to platelet response in patients with treatment refractory immune thrombocytopenia.
    DasGupta RK; Levine L; Wiczer T; Cataland S
    J Oncol Pharm Pract; 2019 Apr; 25(3):567-576. PubMed ID: 29298625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Romiplostim in chronic immune thrombocytopenic purpura.
    Cersosimo RJ
    Clin Ther; 2009 Sep; 31(9):1887-907. PubMed ID: 19843480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.
    Zeller MP; Heddle NM; Kelton JG; Hamilton K; Wang G; Sholapur N; Carruthers J; Hsia C; Blais N; Toltl L; Hamm C; Pearson MA; Arnold DM
    Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.
    Deuson R; Danese M; Mathias SD; Schoonen M; Fryzek J
    J Med Econ; 2012; 15(5):956-76. PubMed ID: 22533524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Romiplostim for the Treatment of Immune Thrombocytopenia: Spotlight on Patient Acceptability and Ease of Use.
    Gilbert MM; Grimes AB; Kim TO; Despotovic JM
    Patient Prefer Adherence; 2020; 14():1237-1250. PubMed ID: 32801654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe romiplostim-induced rebound thrombocytopenia after splenectomy for refractory ITP.
    Choe MJ; Packer CD
    Ann Pharmacother; 2015 Jan; 49(1):140-4. PubMed ID: 25325908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain.
    Mingot-Castellano ME; Grande-García C; Valcárcel-Ferreiras D; Conill-Cortés C; de Olivar-Oliver L
    Case Rep Hematol; 2017; 2017():4109605. PubMed ID: 28695025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.
    Kuter DJ; Newland A; Chong BH; Rodeghiero F; Romero MT; Pabinger I; Chen Y; Wang K; Mehta B; Eisen M
    Br J Haematol; 2019 May; 185(3):503-513. PubMed ID: 30793285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.
    Osman ME
    Sudan J Paediatr; 2012; 12(2):60-4. PubMed ID: 27493347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Romiplostim during pregnancy as a rescue therapy in primary immune thrombocytopenia: Literature review and case description.
    Rosa María RN; Laura RL; Ángeles PB; Laura LB
    Platelets; 2020; 31(3):403-406. PubMed ID: 31116059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.
    Sivera P; Ruella M; Gueli A; Hu H; Wade M; Tarella C
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):331-4. PubMed ID: 22343685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia.
    Michel M; Wasser J; Godeau B; Aledort L; Cooper N; Tomiyama Y; Khellaf M; Wang X
    Ann Hematol; 2015 Dec; 94(12):1973-80. PubMed ID: 26341755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Romiplostim for the management of perioperative thrombocytopenia.
    Al-Samkari H; Marshall AL; Goodarzi K; Kuter DJ
    Br J Haematol; 2018 Jul; 182(1):106-113. PubMed ID: 29767837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).
    Gernsheimer TB; George JN; Aledort LM; Tarantino MD; Sunkara U; Matthew Guo D; Nichol JL
    J Thromb Haemost; 2010 Jun; 8(6):1372-82. PubMed ID: 20230419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
    Newland A; Godeau B; Priego V; Viallard JF; López Fernández MF; Orejudos A; Eisen M
    Br J Haematol; 2016 Jan; 172(2):262-73. PubMed ID: 26537623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Romiplostim in the management of the thrombocytopenic surgical patient.
    Marshall AL; Goodarzi K; Kuter DJ
    Transfusion; 2015 Oct; 55(10):2505-10. PubMed ID: 26033367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.